Quadrant Capital Group LLC Adaptive Biotechnologies Corp Transaction History
Quadrant Capital Group LLC
- $2.65 Billion
- Q1 2025
A detailed history of Quadrant Capital Group LLC transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Quadrant Capital Group LLC holds 9,635 shares of ADPT stock, worth $100,011. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,635
Previous 8,876
8.55%
Holding current value
$100,011
Previous $53,000
33.96%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding ADPT
# of Institutions
246Shares Held
156MCall Options Held
44.3KPut Options Held
47.8K-
Viking Global Investors LP30MShares$311 Million0.74% of portfolio
-
Rubric Capital Management LP New York, NY13.1MShares$136 Million2.79% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$121 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.1MShares$116 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl7.73MShares$80.3 Million0.62% of portfolio
About Adaptive Biotechnologies Corp
- Ticker ADPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 142,872,992
- Market Cap $1.48B
- Description
- Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...